Epigenetics at the intersection of cancer, immunity, and metabolism
The Capell Lab seeks to understand epigenetic and epitranscriptomic gene regulatory mechanisms, how they interface with metabolism and the immune system, and how when disrupted, they may contribute to disease, and in particular, cancer. By combining the incredible accessibility of human skin with the most cutting-edge epigenetic and epitranscriptomic techniques, we aim to identify therapeutic vulnerabilities in cancer, and novel targets to treat disease.
We invite you to explore our website to learn more about our research program and its members.
Brian Capell, MD, PhD 2 hours, 45 minutes ago
Brian Capell, MD, PhD 1 day, 23 hours ago
Brian Capell, MD, PhD 1 week ago